References
- Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Ericsson SR, . Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006;45:787–95.
- Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, . Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45: 323–9.
- Tsujino K, Hirota S, Endo M, Obayashi K, Kotani Y, Satouchi M, . Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003;55:110–5.
- Korreman S, Mostafavi H, Le QT, Boyer A. Comparison of respiratory surrogates for gated lung radiotherapy without internal fiducials. Acta Oncol 2006;45:935–42.
- Nottrup TJ, Korreman SS, Pedersen AN, Persson GF, Aarup LR, Nystrom H, . Interfractional changes in tumour volume and position during entire radiotherapy courses for lung cancer with respiratory gating and image guidance. Acta Oncol 2008;47:1406–13.
- Slotman BJ, Lagerwaard FJ, Senan S. 4D imaging for target definition in stereotactic radiotherapy for lung cancer. Acta Oncol 2006;45:966–72.
- Fox T, Simon EL, Elder E, Riffenburgh RH, Johnstone PAS. Free breathing gated delivery (FBGD) of lung radiation therapy: Analysis of factors affecting clinical patient throughput. Lung Cancer 2007;56:69–75.
- Berbeco RI, Nishioka S, Shirato H, Chen GTY, Jiang SB. Residual motion of lung tumours in gated radiotherapy with external respiratory surrogates. Phys Med Biol 2005;50: 3655–67.
- Vedam SS, Keall PJ, Kini VR Mohan R. Determining parameters for respiratory-gated radiotherapy. Med Phys 2001; 28:2139–46.
- Saito T, Sakamoto T, Oya N. Predictive factors for lung dose reduction by respiratory gating at radiotherapy for lung cancer. J Radiat Res 2010;51:691–8.
- Saito T, Sakamoto T, Oya N. Comparison of gating around end-expiration and end-inspiration in radiotherapy for lung cancer. Radiother Oncol 2009;93:430–5.
- Turner AC, Zankl M, DeMarco JJ, Cagnon CH, Zhang D, Angel E, . The feasibility of a scanner-independent technique to estimate organ dose from MDCT scans: Using CTDIvol to account for differences between scanners. Med Phys 2010;37:1816–25.
- Paludan M, Hansen AT, Petersen J, Grau C, Hoyer M. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? Acta Oncol 2006;45:818–22.